Capital Fund Management (CFM)
INFI

Capital Fund Management (CFM)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Capital Fund Management (CFM)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-211,156
Closed -$4.04M – 1963
2013
Q2 		$3.43M Buy
+211,156
New +$6.53M 0.05% 461

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Capital Fund Management (CFM)'s INFI Position: Q3 2013 in Review

Capital Fund Management (CFM) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2013, closing a stake of 211,156 shares — an estimated $4.04M sold.

Capital Fund Management (CFM) first reported a position in INFI in Q2 2013 and held it in 1 quarter. The position peaked at $3.43M in Q2 2013. 100 funds tracked by Wall St. Rank hold INFI as of Q3 2013.

  • Capital Fund Management (CFM) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 211,156 Infinity Pharmaceuticals, Inc. shares in Q3 2013, an estimated $4.04M.
  • Capital Fund Management (CFM) first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Infinity Pharmaceuticals, Inc. position peaked at $3.43M in Q2 2013.
  • 100 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2013.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2013, filed 31 Oct 2013.